Insider Transactions in Q4 2021 at Silk Road Medical Inc (SILK)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 13
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-7.03%
|
$400,000
$40.95 P/Share
|
Dec 13
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.57%
|
$10,000
$1.6 P/Share
|
Nov 30
2021
|
Erica J. Rogers President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+1.86%
|
$102,500
$41.3 P/Share
|
Nov 16
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-5.26%
|
$500,000
$50.32 P/Share
|
Nov 16
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.0%
|
$40,000
$4.73 P/Share
|
Nov 11
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
18,095
-4.33%
|
$904,750
$50.58 P/Share
|
Nov 11
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,738
+5.29%
|
$15,738
$1.53 P/Share
|
Nov 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,805
-1.32%
|
$288,300
$60.96 P/Share
|
Nov 01
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,805
+1.28%
|
$105,710
$22.77 P/Share
|
Oct 27
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-2.7%
|
$590,000
$59.39 P/Share
|
Oct 27
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.63%
|
$120,000
$12.15 P/Share
|
Oct 11
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-7.69%
|
$605,000
$55.73 P/Share
|
Oct 11
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+7.14%
|
$11,000
$1.6 P/Share
|
Oct 01
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,658
-1.46%
|
$146,190
$55.24 P/Share
|
Oct 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,324
-4.3%
|
$335,172
$53.9 P/Share
|
Oct 01
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,324
+4.12%
|
$25,296
$4.73 P/Share
|